Literature DB >> 18534917

Antihypertensive and vasorelaxant activities of Laelia autumnalis are mainly through calcium channel blockade.

Jorge Vergara-Galicia1, Rolffy Ortiz-Andrade, Patricia Castillo-España, Maximiliano Ibarra-Barajas, Itzell Gallardo-Ortiz, Rafael Villalobos-Molina, Samuel Estrada-Soto.   

Abstract

The aim of the present study was to evaluate the possible mechanism of the vasorelaxant action of methanol extract from Laelia autumnalis (MELa) in isolated rat aortic rings, and to establish its antihypertensive activity in vivo. MELa (0.15-->50 microg/mL) induced relaxation in aortic rings pre-contracted with KCl (80 mM), showing an IC50 value of 34.61+/-1.41 microg/mL and E max value of 85.0+/-4.38% (in endothelium-intact rings) and an IC50 value of 45.11+/-4.17 microg/mL and E max value of 80.0+/-12.1% (in endothelium-denuded rings). Serotonin (5-HT, 1 x 10(-4) M) provoked sustained contraction, which was markedly inhibited by MELa (0.15-->50 microg/mL) in a concentration-dependent and endothelium-independent manner. Pretreatment with MELa (15, 46, 150, 300 and 1500 microg/mL) also inhibited contractile responses to norepinephrine (NE 1 x 10(-11) M to 1 x 10(-5.5) M). In endothelium-denuded rings, the vasorelaxant effect of MELa was reduced partially by ODQ (1 microM), but not by tetraethylammonium (5 microM), glibenclamide (10 microM), and 2-aminopyridine (100 microM). The extract also reduced NE-induced transient contraction in Ca2+-free solution, and inhibited contraction induced by increasing external calcium in Ca2+-free medium plus high KCl (80 mM). The antihypertensive effect of MELa was determined in spontaneously hypertensive rats (SHR). A single oral administration of the extract (100 mg/kg) exhibited a significant decrease in systolic and diastolic blood pressure and heart rate (p<0.05) in SHR rats. Our results suggest that MELa induces relaxation in rat aortic rings through an endothelium-independent pathway, involving blockade of Ca2+ channels and a possible cGMP enhanced concentrations and also causes an antihypertensive effect.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18534917     DOI: 10.1016/j.vph.2008.04.002

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN: 1537-1891            Impact factor:   5.773


  1 in total

1.  The novel analogue of hirsutine as an anti-hypertension and vasodilatary agent both in vitro and in vivo.

Authors:  Kai Zhu; Su-Na Yang; Fen-Fen Ma; Xian-Feng Gu; Yi-Chun Zhu; Yi-Zhun Zhu
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.